https://www.selleckchem.com/pr....oducts/lanraplenib.h
To evaluate the impact of a colorectal cancer (CRC) risk predicting system on CRC mortality rates. An organized population screening program targeted at all the subjects (n = 102,076) at age 40-74 in nine towns of Jiashan county, China was conducted from 2007 to 2012. All of the screening participants were first triaged into high-risk low-risk groups by a questionnaire and two fecal immunuochemical tests, only the high-risk subjects were subject to colonocopy. The screening participants were surveyed death caused by CRC for a